Mark Lee Barr, MD

Associate Professor of Surgery

Chair for the Department's Appointments, Promotion and Tenure Committee

Director of Cardiac Surgery Clearkship

Image of Mark Lee Barr, MD
Is this your profile? Click to edit

Overview

Dr. Mark L. Barr obtained his medical degree from Mount Sinai School of Medicine and completed 10 years of postgraduate residency at New York University and Columbia University, including a 2-year NIH-sponsored research fellowship in transplantation immunology. He is a tenured faculty member in the Department of Surgery and serves as Co-Director of the USC Transplantation Institute; Chair of the Department of Surgery Appointments, Promotions, and Tenure Committee; and Director of the Cardiothoracic Surgery Medical Student Clerkship. He has served as Chair of the UNOS Thoracic Transplantation Committee, as President of the International Society for Heart and Lung Transplantation (ISHLT), as Chair of the Thoracic Committee of the American Society of Transplant Surgeons (ASTS), and on the Board of Directors of the ISHLT, the ASTS, the American Society of Transplantation, and the Board of Directors of the OPTN / UNOS. Dr. Barr was the Chair of the Advisory Committee on Transplantation (ACOT) under the auspices of the Secretary of the Department of Health and Human Services during the 8 years of the Obama administration. He is an author / co-author on more than 150 peer-reviewed publications and book chapters in the fields of cardiothoracic surgery and heart and lung transplantation, has served on multiple scientific review boards for NIAID, NHLBI, and NCRR of the National Institutes of Health, and was a Deputy Editor of the American Journal of Transplantation for 15 years.

Publications

  • Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant. 2000 Apr; 14(2):162-6.. View in PubMed
  • Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg. 1999 Dec; 68(6):2279-83.. View in PubMed
  • Addition of a water-soluble alpha-tocopherol analogue to University of Wisconsin solution improves endothelial viability and decreases lung reperfusion injury. J Surg Res. 1999 Sep; 86(1):145-9.. View in PubMed
  • Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection. J Thorac Cardiovasc Surg. 1999 Apr; 117(4):714-8.. View in PubMed
  • A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant. 1999 Apr; 18(4):336-45.. View in PubMed
  • A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin solutions in lung reperfusion injury. Transplantation. 1999 Jan 15; 67(1):152-5.. View in PubMed
  • Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med. 1998 Dec 10; 339(24):1744-51.. View in PubMed
  • Recipient and donor outcomes in living related and unrelated lobar transplantation. Transplant Proc. 1998 Aug; 30(5):2261-3.. View in PubMed
  • Living donor lobar lung transplantation: the pediatric experience. Pediatr Transplant. 1998 Aug; 2(3):185-90.. View in PubMed
  • Photopheresis in transplantation: future research and directions. Transplant Proc. 1998 Aug; 30(5):2248-50.. View in PubMed